Seers

씨어스 · 458870

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$813.6M (₩1.1T)

Overview

Seers makes wearable heart-monitoring devices and AI-powered software that help doctors detect irregular heart rhythms, a condition called arrhythmia, in patients.

Hospitals, clinics, and health-screening centres across South Korea use its two services: mobiCARE™ for outpatient ECG analysis and thynC™ for real-time vital-sign monitoring of admitted patients. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, the company's core business model is a subscription-based service through which medical institutions access its devices and AI analysis platform without large upfront equipment costs.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$34.9M

▲ +494.7% YoY

Operating profit · FY2025

US$11.8M

Turned profitable

Net income · FY2025

US$11.6M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2024	FY2025
Revenue	US$5.9M(₩8.1B)	US$34.9M(₩48.2B)
Operating profit	−US$6.3M(−₩8.7B)	US$11.8M(₩16.3B)
Net income	−US$6.4M(−₩8.9B)	US$11.6M(₩16B)

Revenue

FY2024US$5.9M
FY2025US$34.9M

Operating profit

FY2024−US$6.3M
FY2025US$11.8M

Net income

FY2024−US$6.4M
FY2025US$11.6M

Key ratios (FY2025)

ROE

40.5%

Debt/Eq

36.8%

Op. margin

33.9%

Net margin

33.3%

Rev. YoY

▲ +494.7%

Why it matters

Its subscription model is structured to fit within South Korea's national health-insurance reimbursement framework, which governs how diagnostic tests are billed and paid for domestically.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?